Leaders in Learning: Publications of Faculty & Staff

Agarwal, V., M.P. McRae, A. Bhardwaj, and R.W. Teasell. 2003. A model to aid in the prediction of discharge location for stroke rehabilitation patients. Archives Physical Medicina and Rehabilitation 84 (11): 1703-1709.

DEATHE, A.B.

Miller, W.C., A.B. Deathe, and J. Harris. 2004. Measurement properties of the Frenchay Activities Index among individuals with a lower limb amputation. Clinical Rehabilitation 18 (4): 414-422.

DOHERTY T.J.

Boe, S.G., D.W. Stashuk, and Doherty T.J. 2004. Motor unit number estimation by decomposition-enhanced spike triggered averaging: control data, test-retest reliability, and contractile level effects. Muscle Nerve 29 (5): 693-699.

Doherty, T.J. 2003. Invited reveiw: Aging & sarcopenia. Applied Physiology 95 (4): 1717-1727.

Doherty, T.J., and D.W. Stashuk. 2003. Decomposition-based quantitative electromyography: methods and initial normative data in five muscles. Muscle Nerve 28 (2): 204-211.

Foley, N.C., R.W. Teasell, S.K. Bhogal, T.J. Doherty, and M.R. Speechly. 2003. The efficacy of stroke rehabilitation: a qualitative review. Top Stroke Rehabilitation 10 (2): 1-18.

Tarnopolsky, M., D. Mahoney, T. Thompson, H. Naylor, and Doherty T.J. 2004. Creatine monohydrate supplementation does not increase muscle strenght, lean body mass, or muscle phosphocreatine in patients with myotonic dystrophy type 1. Muscle Nerve 29 (1): 51-58.

Tarnopolsky, M.A., D.J. Mahoney, J. Vajsar, C. Rodriguez, Doherty T.J., B.D. Roy, and D. Biggar. 2004. Creatine monohydrate enhances strenght and body composition Duchenne muscular dystrophy. Neurology 62 (10): 1771-1777.

HAYES K.C.

Hayes K.C., Potter P.J., R.R. Hansebout, J.M. Bugaresti, J.T. Hsieh, S. Nicosia, M.A. Katz, A.R. Blight, and R. Cohen. 2003. Pharmacokinetic studies of single and multiple oral doses of fampridine-SR (sustained-release 4-aminopyridine) in patients with chronic spinal cord injury. Clinical Neuropharmacology 26 (4): 185-192.

Hayes K.C., Potter P.J., J.T. Hsieh, M.A. Katz, A.R. Blight, and R. Cohen. 2004. Pharmacokinetic and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Clinical Neuropharmacology 85 (1): 29-34.

JUTAI, J.W.

Fuhrer, M.J., J.W. Jutai, M.J. Scherer, and F. DeRuyter. 2003. A framework for the conceptual modelling of assistive technology device outcomes. Disability and Rehabilitation 25 (22): 1243-1251.

Jutai, J.W., S.K. Bhogal, N.C. Foley, M. Bayley, R.W. Teasell, and M.R. Speechley. 2003. Treatment of visual perceptual disorders post stroke. Top Stroke Rehabilitation 10 (2): 77-106.

Saunders, G.H., and J.W. Jutai. 2004. Hearing specific and generic measures of the psychosocial impact of hearing aids. Journal of the Amrican Academy of Audiology 15 (3): 238-248.

Steele, C.A., I.V. Kalnins, B.E. Rossen, D.W. Biggar, J.A. Bortolussi, and J.W. Jutai. 2004. Age-related health risk behaviors of adolescents with physical disabilities. Social & Preventive Medicine 49 (2): 132-141.

MILLER, T.A.

Gordon, K.D., R.D. Pardo, J.A. Johnson, G.J. King, and T.A. Miller. 2003. Electromyographic activity and strength during maximum isometric pronation and supination efforts in healthy adults. Journal of Orthopaedics Research 22 (1): 208-213.

POTTER P.J.

Hayes K.C., Potter P.J., R.R. Hansebout, J.M. Bugaresti, J.T. Hsieh, S. Nicosia, M.A. Katz, A.R. Blight, and R. Cohen. 2003. Pharmacokinetic studies of single and multiple oral doses of fampridine-SR (sustained-release 4-aminopyridine) in patients with chronic spinal cord injury. Clinical Neuropharmacology 26 (4): 185-192.

Hayes K.C., Potter P.J., J.T. Hsieh, M.A. Katz, A.R. Blight, and R. Cohen. 2004. Pharmacokinetic and safety of multiple oral doses of sustained-release 4-aminopyridine (Fampridine-SR) in subjects with chronic, incomplete spinal cord injury. Clinical Neuropharmacology 85 (1): 29-34.

TEASELL, R.W.

Agarwal, V., M.P. McRae, A. Bhardwaj, and R.W. Teasell. 2003. A model to aid in the prediction of discharge location for stroke rehabilitation patients. Archives Physical Medicina and Rehabilitation 84 (11): 1703-1709.

Bhogal, S.K., R.W. Teasell, N.C. Foley, and M.R. Speechley. 2003. Community reintegration after stroke. Top Stroke Rehabilitation 10 (2): 107-129.

Bhogal, S.K., R.W. Teasell, N.C. Foley, and M.R. Speechley. 2004. Lesion location and post stroke depression: systematic review of the methodological limitations in the literature. Stroke 35 (3): 794-802.

Bhogal, S.K., R.W. Teasell, N.C. Foley, and M.R. Speechley. 2003. Rehabilitation of aphasia: more is better. Top Stroke Rehabilitation 10 (2): 66-76.

Foley, N.C., R.W. Teasell, S.K. Bhogal, T.J. Doherty, and M.R. Speechly. 2003. The efficacy of stroke rehabilitation: a qualitative review. Top Stroke Rehabilitation 10 (2): 1-18.

Jutai, J.W., S.K. Bhogal, N.C. Foley, M. Bayley, R.W. Teasell, and M.R. Speechley. 2003. Treatment of visual perceptual disorders post stroke. Top Stroke Rehabilitation 10 (2): 77-106.

Teasell, R.W., and J.M. Arnold. 2004. Alpha-1 adrenoceptor hyperresponsiveness in three neuropathic pain states: complex regional pain syndrome 1, diabetic peripheneuropathic pain and central pain states following spinal cord injury. Pain Research & Management 9 (2): 89-97.

Teasell, R.W., S.K. Bhogal, N.C. Foley, and M.R. Speechley. 2003. Gait retraining post stroke. Top Stroke Rehabilitation 10 (2): 34-65.

Teasell, R.W., N.C. Foley, S.K. Bhogal, and M.R. Speechley. 2003. Early supported discharge in stroke rehabilitation. Top Stroke Rehabilitation 10 (2): 19-33.

Teasell, R.W., and L. Kalra. 2004. What's new in stroke rehabilitation. Stroke 35 (2): 383-385.